300255.SZ
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 23.38
−4.69%Sep 16, 2026, 11:57 UTC
Changshan Pharmaceuticals announced on September 16 that it received investors' online questions in a research session, with Chairman Gao Xiaodong, Board Secretary Liu Zhongying, and CFO Yue Xiaohua receiving them.
Source:Sep 15, 2026, 08:46 UTC
Changshan Pharmaceuticals announced that its heparin sodium injection received a drug registration certificate from Moldova's drug regulatory authority.
Source:Sep 7, 2026, 07:51 UTC
Gao Xiaodong resigned as general manager of Changshan Pharmaceutical, with Chang Yanlu acting as interim general manager.
Source:Aug 3, 2026, 07:47 UTC
Changshan Pharmaceutical announced that its dalteparin sodium injection was provisionally selected in the 12th batch of national centralized drug procurement, with the procurement cycle lasting until December 31, 2029.
Source: